Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase

FASEB Journal

Volumn 25, Issue 12, 2011, Pages 4467-4475

  El Armouche, Ali ^a   Wittköpper, Katrin ^a   Fuller, William ^b   Howie, Jacqueline ^b   Shattock, Michael J ^c   Pavlovic, Davor ^c  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

adrenergic signaling; FXYD1; Heart failure; Sodium pump

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; PEPTIDES AND PROTEINS; PHOSPHOLEMMAN; PHOSPHOPROTEIN PHOSPHATASE 1 INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; VOLTAGE CLAMP; WESTERN BLOTTING;

ANIMALS; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; HEART FAILURE; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; PROTEINS; RATS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 82655181353     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-184903     Document Type: Article

References (47)

1. Fuller, W., Eaton, P., Bell, J. R., and Shattock, M. J. (2004) Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/K-ATPase. FASEB J. 18, 197-199
2. Pavlovic, D., Fuller, W., and Shattock, M. J. (2007) The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K-ATPase. FASEB J. 21, 1539-1546 (Pubitemid 46684855)
3. Han, F., Bossuyt, J., Despa, S., Tucker, A. L., and Bers, D. M. (2006) Phospholemman phosphorylation mediates the protein kinase C-dependent effects on Na+/K+ pump function in cardiac myocytes. Circ. Res. 99, 1376-1383 (Pubitemid 44949673)
4. Fuller, W., Howie, J., McLatchie, L. M., Weber, R. J., Hastie, C. J., Burness, K., Pavlovic, D., and Shattock, M. J. (2009) FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. Am. J. Physiol. Cell Physiol. 296, C1346-C1355
5. Silverman, B. Z., Fuller, W., Eaton, P., Deng, J., Moorman, J. R., Cheung, J. Y., James, A. F., and Shattock, M. J. (2005) Serine 68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K-ATPase. Cardiovasc. Res. 65, 93-103 (Pubitemid 40038482)
6. Bers, D. M., and Despa, S. (2009) Na/K-ATPase-an integral player in the adrenergic fight-or-flight response. Trends Cardiovasc. Med. 19, 111-118
7. Despa, S., Tucker, A. L., and Bers, D. M. (2008) Phospholemman-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during beta-adrenergic stimulation in mouse ventricular myocytes. Circulation 117, 1849-1855 (Pubitemid 351507473)
8. Shattock, M. J. (2009) Phospholemman: its role in normal cardiac physiology and potential as a druggable target in disease. Curr. Opin. Pharmacol. 9, 160-166
9. Oliver, C. J., and Shenolikar, S. (1998) Physiologic importance of protein phosphatase inhibitors. Front. Biosci. 3, D961-972
10. Carr, A. N., Schmidt, A. G., Suzuki, Y., del Monte, F., Sato, Y., Lanner, C., Breeden, K., Jing, S. L., Allen, P. B., Greengard, P., Yatani, A., Hoit, B. D., Grupp, I. L., Hajjar, R. J., DePaoli-Roach, A. A., and Kranias, E. G. (2002) Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 22, 4124-4135 (Pubitemid 34556583)
11. Nicolaou, P., Hajjar, R. J., and Kranias, E. G. (2009) Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology. J. Mol. Cell. Cardiol. 47, 365-371
12. MacDougall, L. K., Jones, L. R., and Cohen, P. (1991) Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur. J. Biochem. 196, 725-734
13. Herzig, S., and Neumann, J. (2000) Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol. Rev. 80, 173-210 (Pubitemid 30060564)
14. Wittkopper, K., Eschenhagen, T., and El-Armouche, A. (2010) Phosphatase-1-inhibitor-1: amplifier or attenuator of catecholaminergic stress? Basic Res. Cardiol. 105, 569-571
15. El-Armouche, A., Rau, T., Zolk, O., Ditz, D., Pamminger, T., Zimmermann, W. H., Jackel, E., Harding, S. E., Boknik, P., Neumann, J., and Eschenhagen, T. (2003) Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes. FASEB J. 17, 437-439
16. El-Armouche, A., Bednorz, A., Pamminger, T., Ditz, D., Didie, M., Dobrev, D., and Eschenhagen, T. (2006) Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes. Biochem. Biophys. Res. Commun. 346, 700-706
17. Braz, J. C., Gregory, K., Pathak, A., Zhao, W., Sahin, B., Klevitsky, R., Kimball, T. F., Lorenz, J. N., Nairn, A. C., Liggett, S. B., Bodi, I., Wang, S., Schwartz, A., Lakatta, E. G., DePaoli-Roach, A. A., Robbins, J., Hewett, T. E., Bibb, J. A., Westfall, M. V., Kranias, E. G., and Molkentin, J. D. (2004) PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10, 248-254 (Pubitemid 38667614)
18. El-Armouche, A., Boknik, P., Eschenhagen, T., Carrier, L., Knaut, M., Ravens, U., and Dobrev, D. (2006) Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation 114, 670-680 (Pubitemid 44252309)
19. El-Armouche, A., Pamminger, T., Ditz, D., Zolk, O., and Eschenhagen, T. (2004) Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc. Res. 61, 87-93 (Pubitemid 38056684)
20. Pavlovic, D., McLatchie, L. M., and Shattock, M. J. (2010) The rate of loss of T-tubules in cultured adult ventricular myocytes is species dependent. Exp. Physiol. 95, 518-527
21. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. (1998) A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U. S. A. 95, 2509-2514 (Pubitemid 28145972)
22. Wittkopper, K., Fabritz, L., Neef, S., Ort, K. R., Grefe, C., Unsold, B., Kirchhof, P., Maier, L. S., Hasenfuss, G., Dobrev, D., Eschenhagen, T., and El-Armouche, A. (2010) Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging. J. Clin. Invest. 120, 617-626
23. Nicklin, S. A., and Baker, A. H. (1999) Simple methods for preparing recombinant adenoviruses for high-efficiency transduction of vascular cells. Methods Mol. Med. 30, 271-283
24. Nishi, A., Fisone, G., Snyder, G. L., Dulubova, I., Aperia, A., Nairn, A. C., and Greengard, P. (1999) Regulation of Na+, K+-ATPase isoforms in rat neostriatum by dopamine and protein kinase C. J. Neurochem. 73, 1492-1501 (Pubitemid 29440150)
25. Endo, S., Zhou, X., Connor, J., Wang, B., and Shenolikar, S. (1996) Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor. Biochemistry 35, 5220-5228 (Pubitemid 26129461)
26. Hedou, G. F., Koshibu, K., Farinelli, M., Kilic, E., Gee, C. E., Kilic, U., Baumgartel, K., Hermann, D. M., and Mansuy, I. M. (2008) Protein phosphatase 1-dependent bidirectional synaptic plasticity controls ischemic recovery in the adult brain. J. Neurosci. 28, 154-162
27. Genoux, D., Haditsch, U., Knobloch, M., Michalon, A., Storm, D., and Mansuy, I. M. (2002) Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418, 970-975 (Pubitemid 34976031)
28. El-Armouche, A., Wittkopper, K., Degenhardt, F., Weinberger, F., Didie, M., Melnychenko, I., Grimm, M., Peeck, M., Zimmermann, W. H., Unsold, B., Hasenfuss, G., Dobrev, D., and Eschenhagen, T. (2008) Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc. Res. 80, 396-406
29. Neumann, J., Eschenhagen, T., Jones, L. R., Linck, B., Schmitz, W., Scholz, H., and Zimmermann, N. (1997) Increased expression of cardiac phosphatases in patients with end-stage heart failure. J. Mol. Cell. Cardiol. 29, 265-272 (Pubitemid 27129150)
30. Bollen, M., Peti, W., Ragusa, M. J., and Beullens, M. (2010) The extended PP1 toolkit: designed to create specificity. Trends Biochem. Sci. 35, 450-458
31. Zalk, R., Lehnart, S. E., and Marks, A. R. (2007) Modulation of the ryanodine receptor and intracellular calcium. Annu. Rev. Biochem. 76, 367-385
32. 2+ exchange in adult rat cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 288, H2342-H2354
33. Carr, A. N., Sutliff, R. L., Weber, C. S., Allen, P. B., Greengard, P., de Lanerolle, P., Kranias, E. G., and Paul, R. J. (2001) Is myosin phosphatase regulated in vivo by inhibitor-1? Evidence from inhibitor-1 knockout mice. J. Physiol. 534, 357-366 (Pubitemid 32677733)
34. Berry, R. G., Despa, S., Fuller, W., Bers, D. M., and Shattock, M. J. (2007) Differential distribution and regulation of mouse cardiac Na+/K+-ATPase alpha1 and alpha2 subunits in T-tubule and surface sarcolemmal membranes. Cardiovasc. Res. 73, 92-100 (Pubitemid 44937202)
35. Virshup, D. M., and Shenolikar, S. (2009) From promiscuity to precision: protein phosphatases get a makeover. Mol. Cell 33, 537-545
36. Schutz, W., and Freissmuth, M. (1992) Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol. Sci. 13, 376-380
37. i and contractility in nonfailing and failing human myocardium Circulation 106, 447-453
38. Despa, S., Islam, M. A., Weber, C. R., Pogwizd, S. M., and Bers, D. M. (2002) Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation 105, 2543-2548 (Pubitemid 34568978)
39. Baartscheer, A., Schumacher, C. A., van Borren, M. M., Belterman, C. N., Coronel, R., and Fiolet, J. W. (2003) Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc. Res. 57, 1015-1024 (Pubitemid 36324606)
40. Lee, C. O., and Dagostino, M. (1982) Effect of strophanthidin on intracellular Na ion activity and twitch tension of constantly driven canine cardiac Purkinje fibers. Biophys. J. 40, 185-198 (Pubitemid 13149889)
41. Bers, D. M., and Despa, S. (2006) Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts. J. Pharmacol. Sci. 100, 315-322 (Pubitemid 44609526)
42. Heineke, J., and Molkentin, J. D. (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol. 7, 589-600 (Pubitemid 44325350)
43. Allen, P. D., Schmidt, T. A., Marsh, J. D., and Kjeldsen, K. (1992) Na, K-ATPase expression in normal and failing human left ventricle. Basic Res. Cardiol. 87(Suppl. 1), 87-94
44. Semb, S. O., Lunde, P. K., Holt, E., Tonnessen, T., Christensen, G., and Sejersted, O. M. (1998) Reduced myocardial Na+, K(+)-pump capacity in congestive heart failure following myocardial infarction in rats. J. Mol. Cell. Cardiol. 30, 1311-1328 (Pubitemid 28345033)
45. Verdonck, F., Volders, P. G., Vos, M. A., and Sipido, K. R. (2003) Increased Na+ concentration and altered Na/K pump activity in hypertrophied canine ventricular cells. Cardiovasc. Res. 57, 1035-1043 (Pubitemid 36324608)
46. Bossuyt, J., Ai, X., Moorman, J. R., Pogwizd, S. M., and Bers, D. M. (2005) Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure. Circ. Res. 97, 558-565 (Pubitemid 41361746)
47. Schwinger, R. H., Wang, J., Frank, K., Muller-Ehmsen, J., Brixius, K., McDonough, A. A., and Erdmann, E. (1999) Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Circulation 99, 2105-2112